ArticleAmerican journal of translational research2025
Impact of nasal high-flow humidified oxygen therapy on oxygenation index and respiratory function in patients with Stanford Type B aortic dissection and hypoxemia.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the efficacy of nasal high-flow humidified oxygen therapy (HFHO) in improving oxygenation and respiratory function.
methodsThis retrospective analysis included 193 patients with Stanford Type B aortic dissection and hypoxemia admitted to Xingtai People's Hospital from January 2020 to January 2023. Patients were divided into two groups: HFHO (n = 107) and conventional oxygen therapy (CO, n = 125). The primary endpoints included changes in the oxygenation index (PaO
resultsBaseline demographic and disease characteristics were similar between groups (all P > 0.05). The HFHO group displayed a significant improvement in PaO
conclusionHFHO offers superior outcomes in oxygenation and respiratory function compared to conventional oxygen therapy in patients with Stanford Type B aortic dissection and hypoxemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.